Your session is about to expire
← Back to Search
Behavioral Intervention
VR Therapy for Bone Marrow Transplant
N/A
Recruiting
Led By Areej El-Jawahri, MD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to week-24
Awards & highlights
Study Summary
This trial seeks to test a VR psychosocial intervention to improve quality of life and reduce distress in BMT patients.
Who is the study for?
This trial is for English-speaking adults over 18 with blood cancer, admitted for bone marrow transplantation (BMT). It's not suitable for those with benign blood conditions or acute psychiatric/cognitive issues that prevent informed consent or following the study.Check my eligibility
What is being tested?
The study tests a virtual reality (VR) program designed to improve life quality and reduce stress in BMT patients. Participants will either receive this VR intervention plus standard care, or just standard care, assigned randomly.See study design
What are the potential side effects?
Since the intervention involves VR experiences, potential side effects may include mild discomfort like dizziness, headache, eye strain or emotional distress but are generally minimal compared to medical interventions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to week-24
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to week-24
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Feasibility of BMT-VR based on enrollment and intervention use rates
Secondary outcome measures
Anxiety symptoms
Depression symptoms
Post-Traumatic Stress Disorder (PTSD)
+2 moreOther outcome measures
Coping
Gratitude
Optimism
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: BMT-VR GroupExperimental Treatment1 Intervention
Participants will complete the BMT-VR intervention during their BMT hospitalization, which contains six sections.
Participants will receive usual transplant care by their BMT team
Participants will complete study questionnaires to assess their quality of life and psychological outcomes
10-20 participants will complete exit interviews to ascertain more feedback on the BMT-VR intervention.
Group II: Usual careActive Control1 Intervention
Participants will receive usual transplant care by their BMT team
Participants will complete study questionnaires to assess their quality of life and psychological outcomes
Find a Location
Who is running the clinical trial?
Massachusetts General HospitalLead Sponsor
2,934 Previous Clinical Trials
13,198,501 Total Patients Enrolled
1 Trials studying Bone Marrow Transplant Complications
120 Patients Enrolled for Bone Marrow Transplant Complications
Areej El-Jawahri, MDPrincipal InvestigatorMassachusetts General Hospital
18 Previous Clinical Trials
4,432 Total Patients Enrolled
1 Trials studying Bone Marrow Transplant Complications
120 Patients Enrolled for Bone Marrow Transplant Complications
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am receiving a bone marrow transplant as an outpatient.I am over 18 and have a blood cancer, scheduled for a bone marrow transplant.I am having a bone marrow transplant for a non-cancerous blood condition.
Research Study Groups:
This trial has the following groups:- Group 1: BMT-VR Group
- Group 2: Usual care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies within this research endeavor for participants?
"Clinicaltrials.gov indicates that since November 17th, 2022 this trial has been inactive and no longer recruiting patients. Nonetheless, 4 other active clinical trials are actively seeking participants as of now."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger